TOMANDL, Josef, Jiří PAŘENICA, Eva TÁBORSKÁ, Lenka ŠPINAROVÁ, Zdeňka ČERMÁKOVÁ and Jindřich ŠPINAR. Neopterin and oxidative stress in patients with heart failure. In Book of abstracts from the conference Synthetic and natural compounds in cancer therapy and prevention. 1st ed. Bratislava: Mind and Helth, civil association, 2007, p. 97-97. ISBN 978-80-969663-2-5.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Neopterin and oxidative stress in patients with heart failure
Name in Czech Neopterin a oxidační stres u pacientů se srdečním selháním
Authors TOMANDL, Josef, Jiří PAŘENICA, Eva TÁBORSKÁ, Lenka ŠPINAROVÁ, Zdeňka ČERMÁKOVÁ and Jindřich ŠPINAR.
Edition 1. vyd. Bratislava, Book of abstracts from the conference Synthetic and natural compounds in cancer therapy and prevention. p. 97-97, 1 pp. 2007.
Publisher Mind and Helth, civil association
Other information
Original language English
Type of outcome Proceedings paper
Field of Study 10600 1.6 Biological sciences
Country of publisher Slovakia
Confidentiality degree is not subject to a state or trade secret
Organization unit Faculty of Medicine
ISBN 978-80-969663-2-5
Keywords in English heart failure; oxidative stress; neopterin; cell-mediated immunity
Tags cell-mediated immunity, Heart failure, neopterin, oxidative stress
Tags International impact
Changed by Changed by: doc. RNDr. Josef Tomandl, Ph.D., učo 47. Changed: 3/4/2007 15:44.
Abstract
Recent data suggest among others that inflammation and oxidative stress may be associated with the development of heart failure. Neopterin is a sensitive marker for disease involving activated cell-mediated immune system in humans and besides induce oxidative stress in vitro. The aim of our study was to determine neopterin levels in patients with acute myocardial infarction (AMI) and chronic heart failure (CHF) and find a possible relationship with parameters of oxidative stress. The results of our study confirm an existence of T-lymphocyte activation, more in patients with ischemic origin of heart failure than cardiomyopathy. Moreover, cell-mediated activation of immune system might be independent on the time of progression of ischemic heart failure.
Abstract (in Czech)
The results of our study confirm an existence of T-lymphocyte activation, more in patients with ischemic origin of heart failure than cardiomyopathy. Moreover, cell-mediated activation of immune system might be independent on the time of progression of ischemic heart failure.
Links
MSM0021622402, plan (intention)Name: Časná diagnostika a léčba kardiovaskulárních chorob
Investor: Ministry of Education, Youth and Sports of the CR, Early diagnostics and treatment of cardiovascular diseases
PrintDisplayed: 28/4/2024 16:43